[Federal Register Volume 73, Number 116 (Monday, June 16, 2008)]
[Notices]
[Pages 34023-34024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-13493]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women with a Recent 
History of Gestational Diabetes Mellitus, Potential Extramural Project 
(PEP) 2008-R-04

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Date: 1 p.m.-4 p.m., June 18, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463. This notice 
was published in the Federal Register on April 17, 2008, Volume 73, 
Number 75, page 20927. Additional time is required to complete the 
review of all applications submitted for this PEP.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Type-2 Diabetes Prevention in Women 
with a Recent History of Gestational Diabetes Mellitus, PEP 2008-R-
04.''
    The National Center for Health Marketing determines that agency 
business requires its consideration of this matter on less than 15 
days notice to the public and that no earlier notice of the meeting 
was possible.
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404)498-1194. The Director, Management 
Analysis and Services Office, has been delegated the authority to 
sign Federal Register notices pertaining to announcements of 
meetings and other committee management activities, for both CDC and 
the Agency for Toxic Substances and Disease Registry.


[[Page 34024]]


    Dated: June 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-13493 Filed 6-13-08; 8:45 am]
BILLING CODE 4163-18-P